Disclosure statement
Dr. Ruberg acknowledges consulting agreements with Prothena Pharmaceuticals, Alnylam Pharmaceuticals and Caelum Biosciences. Dr. Berk acknowledges a consulting agreement with Alnylam Pharmaceuticals. All other authors have nothing to disclose.